TY - JOUR
AB - Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that the Transwell cell migration assay data shown in Fig. 2C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Experimental and Therapeutic Medicine, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Experimental and Therapeutic Medicine 14: 1547‑1553, 2017; DOI: 10.3892/etm.2017.4648]
AD - Department of Orthopedics, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China
AU - Wang,Zili
AU - Zheng,Chenhuang
AU - Jiang,Kunqi
AU - He,Jinshen
AU - Cao,Xu
AU - Wu,Song
DA - 2021/12/01
DO - 10.3892/etm.2021.10845
IS - 6
JO - Exp Ther Med
KW - osteosarcoma
microRNA
proliferation
invasion
insulin-like growth factor 1 receptor
PY - 2021
SN - 1792-0981
1792-1015
SP - 1409
ST - [Retracted] MicroRNA‑503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin‑like growth factor 1 receptor
T2 - Experimental and Therapeutic Medicine
TI - [Retracted] MicroRNA‑503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin‑like growth factor 1 receptor
UR - https://doi.org/10.3892/etm.2021.10845
VL - 22
ER -